GleamWall
中文EN

MBOT Microbot Medical Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 883975 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-42.3%
TTM EPS YoY40.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-26.3%
ROA-24.8%
ROIC (approx.)-25.2%
Asset turnover—

Leverage & solvency

Liabilities / assets7.0%
Debt / equity0.00x
Current ratio15.70x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.03x
Accruals ratio0.8%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
R&D expense$6.28M$6.63M
SG&A expense$8.46M$5.00M
Operating income-$14.74M-$11.62M
Net income-$13.14M-$11.44M
EBITDA-$14.70M-$11.53M
EPS (basic)-0.29-0.73
EPS (diluted)-0.29-0.73
Weighted avg. shares (diluted)45.79M15.64M
Balance sheet
Cash & equivalents$3.91M$3.11M
Short-term investments$74.68M$2.36M
Inventory$584,000—
Current assets$79.82M$5.82M
PP&E, net$93,000$80,000
Total assets$81.54M$6.03M
Current liabilities$3.42M$2.46M
Total liabilities$3.99M$2.50M
Shareholders' equity$77.55M$3.53M
Shares outstanding67.16M19.40M
Cash flow statement
Operating cash flow-$13.05M-$8.83M
Capital expenditure$60,000$25,000
Free cash flow-$13.11M-$8.85M
Investing cash flow-$72.38M$1.54M
Financing cash flow$86.24M$7.94M
Depreciation & amortization$47,000$91,000
Stock-based compensation$1.06M$1.35M

Free plan shows the latest 2 periods; Pro shows all 18 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.